Skip to main content
Caplight Logo









TrueClaim

TrueClaim

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.trytrueclaim.com/

Last Round

Pre Seed

Apr 30, 2024

Total Funding Raised

$2.1M

Company Overview

TrueClaim is a healthcare technology company that provides an AI-powered third-party administrator (TPA) platform for self-insured employers to manage and reduce healthcare costs.

Sector

Healthcare & Life Sciences

Verticals

InsurTech, Healthcare Analytics, Vertical SaaS, Revenue Cycle

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

third-party administratorTPAclaims adjudicationself-insured employershealthcare cost containmentAI-native TPAclaims processingbenefits analyticsbilling error detectionhealth plan administrationinsurtechvertical SaaSrevenue cycle managementhealthcare spend managementAI claims audit

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TrueClaim Comparables

Compare TrueClaim with similar companies based on industry and business-model similarity.

TrueClaim comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Avant Health
90%
Health Cost IQ
81%
Marpai, Inc.
73%

TrueClaim Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedApr 30, 2024

Key People

Founding team and executive leadership

Bobby Bayer

CTO Co-Founder

Founding Team

Barbora P Howell

CEO & Co-Founder

Founding Team

TrueClaim Investors

Notable investors and investment history

TrueClaim investors
InvestorRounds
KAYAPre Seed
The Explorer FundPre Seed
Orange CollectivePre Seed
Surge Point CapitalPre Seed
Y CombinatorPre Seed
LiquidityPre Seed
Rebel FundPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Monthly visitors grew 314% MoM, reaching 2.2K.

  • Apr 30, 2024

    $2.1M round with participation from Y Combinator.

TrueClaim Filings

Explore SEC and related filing metadata, where available.

TrueClaim filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about TrueClaim's valuation, stock price, and market status.

Is TrueClaim a public or private company?

TrueClaim is a private company.

What is the current stock price of TrueClaim?

TrueClaim is a private company with no public stock price. No recent secondary market data is available.

How much is TrueClaim worth (valuation)?

Valuation information for TrueClaim is not publicly available.

Can I buy TrueClaim stock?

TrueClaim shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was TrueClaim's last funding round?

TrueClaim's most recent funding round was Pre Seed on April 30, 2024.

Who are the main investors in TrueClaim?

Key investors in TrueClaim include The Explorer Fund, Orange Collective, Surge Point Capital, Y Combinator, Rebel Fund.

Will TrueClaim IPO soon?

No public IPO plans have been announced for TrueClaim.

How can I track TrueClaim secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TrueClaim's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range18
Year Founded2023
Last FundingApr 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?